By C.J. Atkins Just in time for Pride month, President Donald Trump and Health Secretary Robert F. Kennedy, Jr., have ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

Duke University says it's "an enormous setback" for creating a vaccine to fight the cause of AIDS. The Trump administration ...

The current presidential administration has ended funding for the Center for HIV/AIDS Vaccine Development (CHAVD), a move that researchers say will likely set efforts to end HIV globally back by a ...

The US Department of Health and Human Services will not extend a grant funding the Center for HIV/AIDS Vaccine Development, work that was led in part by Duke Health.

The Trump administration terminated $258 million in funding to the Center for HIV/AIDS Vaccine Development (CHAVD) Friday, including $129 million for Duke. Researchers were told that the ...

The Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to ...

The grants fund the Duke Consortia for HIV/AIDS Vaccine Development (CHAVD) initiative, which has received two previous federal grants: $350 million in 2005 and $139 million in 2012.

Burton and his colleagues at the Center for HIV/AIDS Vaccine Development — a consortia of researchers at Scripps and Duke University known as CHAVD — have been working on a promising approach ...